This study on juvenile SLE patients aimed to evaluate retrospectively the impact of a tertiary center’s management policy of the disease severity on its long-term progression and cumulative damage development as well as provision of quality-driven medical care (QmC).
Disease activity was assessed by the Physician Global Assessment and SLEDAI-2K, flares by SELENA/SLEDAI, and damage by the pediatric SLICC/DI at diagnosis, 6 months post-diagnosis, and annually thereafter. At the same time, QmC was evaluated by relevant indices and quality of life was captured by the Greek version of the General Health Questionnaire only at the last visit.
A total of 35 patients (25/35 females) aged at diagnosis 5.5–15.16 years (median 11.83) with a median lag time to diagnosis 1.8 months had a follow-up of 5 (35/35) and 10 years (13/35), respectively. The predominant baseline manifestations were consistent with those previously reported. Out of 35 patients, 24 (68.5%) were clinically inactive at year 5, and 5/13 (38%) at year 10. All patients received immunosuppressives and 7/35 biologics in addition. At the end of their follow-up, damage was found in 9/35 patients, but none of them had a neuropsychiatric disorder. Over the study, 28/35 patients were compliant with the QmC recommendations.
An early diagnosis combined with a longitudinal quantitative assessment of the disease activity and severity contributes to the continuous evaluation of the disease state. They are the key determinants for the selection of an early, targeted, and personalized management; they restrict the cumulative damage development and contribute to an optimal outcome.
• Juvenile SLE has a heavier introductory profile than in adults and an unpredictable trajectory.
• The application of contemporary metric tools for assessing the disease state leads to an objective assessment and regimen selection.
• An early diagnosis combined with longitudinal quantitative assessment is a key determinant for an optimal management and a minimal damage development.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Silva CA, Avcin T, Brunner HI (2012) Taxonomy for systemic lupus erythematosus with onset before adulthood. Arthritis Care Res 64:1787–1793
Borgia RE, Ezequiel R, Silverman ED (2015) Childhood onset systemic lupus erythematosus: an update. Curr Opin Rheumatol 27:483–492
Groot N, de Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P et al (2017) European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative. Ann Rheum Dis 76:1788–1796
Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B et al (2017) European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis 76:1965–1973
Nalbanti P, Stefanidou S, Alfantaki S, Siamopoulou A, Trachana M, Pratsidou-Gertsi P et al (2012) A 5-year multicenter comparative study between patients with juvenile and adult-onset systemic lupus erythematicus. Pediatriki:72–85 [article in Greek]
Tucker LB, Uribe AG, Fernandez M, Vila LM, Mc Gwin G, Apte M et al (2008) Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII). Lupus 17:314–322
Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, Mc Donagh JE (2012) Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort. Arthritis Rheum 64:2356–2365
Koutsonikoli A, Trachana M, Heidich AB, Galanopoulou V, Pratsidou-Gertsi P, Garyphallos A (2015) Dissecting the damage in Northern Greek patients with childhood-onset systemic lupus erythematosus: a retrospective cohort study. Rheumatol Int 35:1225–1232
Lam GK, Petri M (2005) Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 23(Suppl 39):S120–S132
Schneider M (2019) Target therapy in SLE. Autoimmun Rev 18:21–24
Nuttall A, Isenberg DA (2013) Assessment of disease activity, damage and quality of life in systemic lupus erythematosus: new aspects. Best Pract Res Clin Rheumatol 27:309–318
Hollander MC, Sage JM, Greenler AJ, Pendl J, Avcin T, Espada G et al (2013) International consensus for provisions of quality-driven care in childhood onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) 65:1416–1423
Mina R, Harris JG, Klein-Gitelman MS, Appenzeller S, Centeville M, Eskra D et al (2016) Initial benchmarking of the quality of medical care of childhood-onset systemic lupus erythematosus. Arthritis Care Res (Hoboken) 68:179–186
Thong B, Olsen NJ (2017) Systemic lupus erythematosus diagnosis and management. The SLE review series: working for a better standard of care. Optimization of lupus treatments requires a personalized approach, assessing risks and benefits in each patient. Rheumatology 56:i3–i13. https://doi.org/10.1093/rheumatology/kew401
Thakral Α, Klein-Gitelman MS (2016) An update on treatment and management of pediatric systemic lupus erythematosus. Rheumatol Ther 3:209–219
Tan EM, Cohen AS, Fries JF, Masi AT, Mc Shane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277
Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR et al (2012) Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 64:2677–2686
Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis 78:1151–1159
Rao V, Gordon C (2014) Advances in the assessment of lupus disease activity and damage. Curr Opin Rheumatol 26:510–519
Petri M, Hellmann D, Hochberg M (1992) Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 19:53–59
Brunner HI, Huggins J, Klein-Gitelman MS (2011) Pediatric SLE—towards a comprehensive management plan. Nat Rev Rheumatol 7:225–233
Gladman DD, Ibanez D, Urowitz MB (2002) Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 29:288–291
Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH et al (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 142:953–962
Lim LS, Pullenayegum E, Feldman B, Lim L, Gladman D, Silverman E (2018) From childhood to adulthood: disease activity trajectories in childhood-onset systemic lupus erythematosus. Arthritis Care Res 70:750–757
Gutierrez-Suarez R, Ruperto N, Gastaldi R, Pistorio A, Felici E, Burgos-Vargas R et al (2006) A proposal for a pediatric version of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index based on the analysis of 1,015 patients with juvenile-onset systemic lupus erythematosus. Arthritis Rheum 54:2989–2996
Becker-Merok A, Nossent HC (2006) Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J Rheumatol 33:1570–1577
Garyfallos G, Karastergiou A, Adamopoulou A, Moutzoukis C, Alagiozidou E, Mala D et al (1991) Greek version of the General Health Questionnaire: accuracy of translation and validity. Acta Physhiatr Scand 84:371–378
Harry O, Yasin S, Brunner H (2018)Childhood-onset systemic lupus erythematosus: a review and update. J Pediatr 196:22–30.e2. https://doi.org/10.1016/j.jpeds.2018.01.045
Al-Mayouf SM, Al Sonbul A (2008) Influence of gender and age of onset on the outcome in children with systemic lupus erythematosus. Clin Rheumatol 27:1159–1162
Carter EE, Barr SG, Clarke AE (2016) The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol 12:605–620
Hiraki LT, Benseler SM, Tyrrell PN, Harvey E, Hebert D, Silverman ED (2009) Ethnic differences in pediatric systemic lupus erythematosus. J Rheumatol 36:2539–2546
Kim H, Levy DM, Silverman ED, Hitchon C, Bernatsky S, Pineau C et al (2019, 2019) A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort. Rheumatology (Oxford):kez006. https://doi.org/10.1093/rheumatology/kez006 [Epub ahead of print]
Costagliola G, Mosca M, Migniorini P, CONSOLINI R (2018) Pediatric systemic lupus erythematosus: learning from longer follow up to adulthood. Front Pediatr 6:144. https://doi.org/10.3389/fped.2018.00144 eCollection 2018
Benseler SM, Silverman ED (2007) Neuropsychiatric involvement in pediatric systemic lupus erythematosus. Lupus 16:564–571
Tunnicliffe DJ, Singh-Grewal D, Chaitow J, Mackie F, Manolios N, Lin MW et al (2016) “Lupus means sacrifices” - the perspectives of adolescents and young adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 68:828–837
Harry O, Crosby LE, Smith AW, Favier L, Aljaberi N, Ting TV et al (2019)Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing? Lupus 28:642–650
The study was conducted in accordance with the Declaration of Helsinki and approved by the hospital’s ethics committee.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Trachana, M., Pratsidou-Gertsi, P., Kanakoudi-Tsakalidou, F. et al. Impact of the longitudinal quantitative assessment of juvenile systemic lupus erythematosus severity on the disease outcome. Clin Rheumatol 40, 675–682 (2021). https://doi.org/10.1007/s10067-020-05252-8
- Childhood-onset SLE
- jSLE clinimetric tools
- jSLE outcome
- jSLE quality-driven care
- jSLE trajectory assessment
- Pediatric SLE